NYSE$MRSH

Marsh & McLennan Cos Inc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Briefing

Marsh reported Q2 2025 revenue of $6.97B with strong risk and insurance brokerage growth.

Second-quarter revenue was $6.97 billion as risk and insurance services benefited from premium rate trends and client retention. Consulting and health segments added diversification while investment income supplemented operating earnings.

  • Q2 revenue $6.97B; brokerage retention remains high.
  • Commercial P&C pricing moderates but exposure growth supports revenue.
  • Consulting and Mercer health solutions diversify earnings.
  • Catastrophe losses and cyber risk shape client demand for coverage.

Headline financials

Total Revenue

$6.97B

Previous: $6.22B+12.1%
EPS (adj)

$2.53

Previous: $2.27+11.5%
Capital Expenditures

-$114M

Previous: -$167M+31.7%
Free Cash Flow

$1.1B

Previous: $958M+14.5%
Net Income

$1.21B

Previous: $1.13B+7.6%
Operating Income

$1.83B

Previous: $1.64B+11.4%
Gross Profit

$6M

Previous: $5M+20.0%
Cash & Equivalents

$1.68B

Previous: $1.65B+1.5%
Total Assets

$58.6B

Previous: $48.6B+20.5%

Revenue & EPS history

Marsh & McLennan · Revenue · Quarterly

$6.97B

Q2 2025+12.1%vs Q2 2024
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Revenue by segment

Marsh & McLennan · $1.14B total across 2 segments · Q3 2023

  • Marsh Mgmt Consulting
    $781M+17.1%
  • Guy Carpenter
    $359M+9.5%

Forward guidance

The filing discusses Marsh's outlook, capital allocation, and key risks for upcoming quarters, including guidance ranges or operating priorities where disclosed in MD&A.

Tailwinds

  • Marsh cites execution and demand supporting the near-term outlook.
  • Liquidity and balance-sheet capacity support operations and shareholder returns.

Headwinds

  • Macro, input costs, and FX may pressure margins quarter to quarter.
  • Segment mix and one-time items can affect comparability versus prior periods.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

+0.2%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+1.9%

Avg return

30 days after

53%

39 / 73 earnings

Positive

+7.7%

Q4 2018

Best reaction

-9.4%

Q2 2011

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.4%+2.3%-8.0%
Q4 2025+3.5%+5.8%+4.8%
Q3 2025-8.5%-7.3%-10.3%
Q2 2025-1.1%+0.8%-3.1%
Q1 2025-4.9%-5.1%+0.0%
Q4 2024+0.7%+1.7%+8.4%
Q3 2024-1.4%-2.7%-2.5%
Q2 2024-1.8%-0.7%+0.6%
Q1 2024+2.4%+2.1%+6.2%
Q4 2023-2.9%-2.8%+2.5%
Q3 2023-1.0%-0.4%+4.3%
Q2 2023+2.2%+3.2%+0.8%
Q1 2023+3.7%+2.4%+4.0%
Q4 2022-0.7%+0.9%-6.5%
Q3 2022-1.3%-2.5%+6.7%
Q2 2022+2.2%+1.5%+11.9%
Q1 2022-2.1%-3.5%-14.1%
Q4 2021-2.4%-0.3%+1.0%
Q3 2021+2.2%+1.8%+2.1%
Q2 2021+3.5%+3.0%+8.9%
Q1 2021+5.4%+6.7%+7.9%
Q4 2020+2.1%+4.9%+7.1%
Q3 2020-3.8%-0.9%+6.4%
Q2 2020+0.9%+1.6%-1.4%
Q1 2020+2.6%+6.0%+11.9%
Q4 2019-3.5%-1.0%-9.8%
Q3 2019+5.8%+6.5%+10.7%
Q2 2019-4.2%-4.1%-3.8%
Q1 2019-1.0%-0.4%+0.8%
Q4 2018+7.7%+9.9%+10.9%
Q3 2018+6.2%+9.1%+10.0%
Q2 2018-3.8%-4.8%-3.9%
Q1 2018-0.2%-1.4%-1.6%
Q4 2017+1.4%-1.5%-1.1%
Q3 2017-4.1%-4.2%-2.5%
Q2 2017-1.9%-1.8%-4.1%
Q1 2017+1.0%+0.9%+4.0%
Q4 2016+4.6%+3.5%+10.1%
Q3 2016-2.7%-2.3%+6.9%
Q2 2016-1.1%-0.6%+1.1%
Q1 2016+1.5%
Q4 2015+3.4%
Q3 2015+2.8%
Q2 2015-0.2%
Q1 2015-0.4%
Q4 2014-0.9%
Q3 2014+2.2%
Q2 2014+1.5%
Q1 2014-1.0%
Q4 2013+2.1%
Q3 2013+0.0%
Q2 2013-0.2%
Q1 2013+2.5%
Q4 2012-0.1%
Q3 2012+0.7%
Q2 2012+1.7%
Q1 2012+2.0%
Q4 2011-1.1%
Q3 2011+0.2%
Q2 2011-9.4%
Q1 2011+0.5%
Q4 2007+0.2%
Q4 2010+0.2%
Q3 2010-2.8%
Q2 2010+2.6%
Q1 2009+2.1%
Q1 2010-0.5%
Q4 2009+0.6%
Q3 2008+1.8%
Q3 2009+1.8%
Q2 2008-1.2%
Q4 2008-1.2%
Q2 2009-1.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro